Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1980 23
1981 19
1982 21
1983 22
1984 22
1985 14
1986 18
1987 21
1988 24
1989 32
1990 50
1991 55
1992 46
1993 45
1994 61
1995 55
1996 65
1997 50
1998 36
1999 46
2000 41
2001 44
2002 53
2003 57
2004 41
2005 51
2006 40
2007 34
2008 34
2009 38
2010 62
2011 63
2012 70
2013 47
2014 54
2015 63
2016 62
2017 39
2018 56
2019 52
2020 55
2021 36
2022 39
2023 28
2024 42
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,821 results

Results by year

Filters applied: . Clear all
Page 1
Ursodiol for hepatobiliary disorders.
Rubin RA, Kowalski TE, Khandelwal M, Malet PF. Rubin RA, et al. Ann Intern Med. 1994 Aug 1;121(3):207-18. doi: 10.7326/0003-4819-121-3-199408010-00009. Ann Intern Med. 1994. PMID: 8017748 Review.
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation.
Labiano I, Agirre-Lizaso A, Olaizola P, Echebarria A, Huici-Izagirre M, Olaizola I, Esparza-Baquer A, Sharif O, Hijona E, Milkiewicz P, Milkiewicz M, González-Romero F, Aspichueta P, Monte MJ, Marin JJG, Vucur M, Luedde T, Marzioni M, Mann DA, Bujanda L, Rodrigues PM, Banales JM, Perugorria MJ. Labiano I, et al. J Hepatol. 2022 Oct;77(4):991-1004. doi: 10.1016/j.jhep.2022.05.044. Epub 2022 Jun 22. J Hepatol. 2022. PMID: 35750136 Free article.
Ursodiol: a cholesterol gallstone solubilizing agent.
Rosenbaum CL, Cluxton RJ Jr. Rosenbaum CL, et al. Drug Intell Clin Pharm. 1988 Dec;22(12):941-5. doi: 10.1177/106002808802201202. Drug Intell Clin Pharm. 1988. PMID: 3072172 Review.
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.
Bowlus CL, Galambos MR, Aspinall RJ, Hirschfield GM, Jones DEJ, Dörffel Y, Gordon SC, Harrison SA, Kremer AE, Mayo MJ, Thuluvath PJ, Levy C, Swain MG, Neff GW, Sheridan DA, Stanca CM, Berg CP, Goel A, Shiffman ML, Vierling JM, Boudes P, Steinberg A, Choi YJ, McWherter CA. Bowlus CL, et al. J Hepatol. 2022 Aug;77(2):353-364. doi: 10.1016/j.jhep.2022.02.033. Epub 2022 Mar 30. J Hepatol. 2022. PMID: 35367282 Free article. Clinical Trial.
Seladelpar: First Approval.
Hoy SM. Hoy SM. Drugs. 2024 Nov;84(11):1487-1495. doi: 10.1007/s40265-024-02114-4. Epub 2024 Nov 22. Drugs. 2024. PMID: 39572508 Review.
Treatment of primary sclerosing cholangitis.
Floreani A, De Martin S. Floreani A, et al. Dig Liver Dis. 2021 Dec;53(12):1531-1538. doi: 10.1016/j.dld.2021.04.028. Epub 2021 May 16. Dig Liver Dis. 2021. PMID: 34011480 Review.
1,821 results